These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 4204715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].
    Baumeister G, Wagner H, Stahl M.
    Klin Wochenschr; 1975 Jun 15; 53(12):571-4. PubMed ID: 811925
    [Abstract] [Full Text] [Related]

  • 6. Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.
    Ostenson CG, Nylén A, Grill V, Gutniak M, Efendić S.
    Diabetologia; 1986 Dec 15; 29(12):861-7. PubMed ID: 3106122
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA, Zeytinoğlu FN.
    Horm Metab Res; 1976 Mar 15; 8(2):92-6. PubMed ID: 177348
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE, Orci L, Kanazawa Y, Jeanrenaud B, Renold AE.
    Acta Isot (Padova); 1970 Mar 15; 10(3):191-204. PubMed ID: 4334397
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A, Ribes G, Mariani MM, Alric R.
    Acta Diabetol Lat; 1973 Mar 15; 10(2):261-82. PubMed ID: 4200420
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    de Heer J, Holst JJ.
    Diabetes; 2007 Feb 15; 56(2):438-43. PubMed ID: 17259389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.